Greg Wolf to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Greg Wolf has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.385
-
Wolf GT, Liu S, Bellile E, Sartor M, Rozek L, Thomas D, Nguyen A, Zarins K, McHugh JB. Tumor infiltrating lymphocytes after neoadjuvant IRX-2 immunotherapy in oral squamous cell carcinoma: Interim findings from the INSPIRE trial. Oral Oncol. 2020 12; 111:104928.
Score: 0.170
-
Chen C, Lohavanichbutr P, Zhang Y, Houck JR, Upton MP, Abedi-Ardekani B, Agudo A, Ahrens W, Alemany L, Anantharaman D, Conway DI, Futran ND, Holcatova I, G?nther K, Hansen BT, Healy CM, Itani D, Kjaerheim K, Monroe MM, Thomson PJ, Witt BL, Nakoneshny S, Peterson LA, Schwartz SM, Zarins KR, Hashibe M, Brennan P, Rozek LS, Wolf G, Dort JC, Wang P. Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples. Oral Oncol. 2020 01; 100:104487.
Score: 0.163
-
Vainshtein J, McHugh JB, Spector ME, Walline HM, Komarck CM, Stenmark MH, Prince ME, Worden FP, Wolf GT, Bradford CR, Chepeha DB, Carey T, Eisbruch A. Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor. Head Neck. 2015 Jan; 37(1):8-11.
Score: 0.027
-
Chandarana SP, Lee JS, Chanowski EJ, Sacco AG, Bradford CR, Wolf GT, Prince ME, Moyer JS, Eisbruch A, Worden FP, Giordano TJ, Kumar B, Cordell KG, Carey TE, Chepeha DB. Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer. Head Neck. 2013 Aug; 35(8):1083-90.
Score: 0.025